Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations

American Journal of Epidemiology

Volumn 163, Issue 2, 2006, Pages 160-170

  Samore, Matthew H ^a   Lipsitch, Marc ^b   Alder, Stephen C ^a   Haddadin, Bassam ^a   Stoddard, Greg ^a   Williamson, Jacquelyn ^a   Sebastian, Katherine ^a   Carroll, Karen ^c   Ergonul, Onder ^b   Carmeli, Yehuda ^a   Sande, Merle A ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cephalosporins; Drug resistance, microbial; Nasopharyngeal diseases; Penicillins; Streptococcus pneumoniae

Indexed keywords

CEPHALOSPORIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CARRIER; DISEASE SIMULATION; HEALTH SURVEY; HUMAN; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; PENICILLIN RESISTANCE; PRESCHOOL CHILD; RURAL POPULATION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, HORIZONTAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IDAHO; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; QUESTIONNAIRES; STREPTOCOCCUS PNEUMONIAE; UTAH;

STREPTOCOCCUS PNEUMONIAE;

EID: 30344460680     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj021     Document Type: Article

References (58)

1. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997;24(suppl 1):S85-S88.
2. Tomasz A. New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae. Am J Med 1999;107:55S-62S.
3. Whitney CG, Farley MM, Adler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
4. Baquero F. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist 1995;1:115-20.
5. Dagan R, Klugman KP, Craig WA, et al. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001;47:129-40.
6. Klugman KP. The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50(suppl S2):1-5.
7. Forward KR. The epidemiology of penicillin resistance in Streptococcus pneumoniae. Semin Respir Infect 1999;14:243-54.
8. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 2003;112:862-9.
9. Turnidge JD, Bell JM, Collignon PJ. Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group. Med J Aust 1999;170:152-5.
10. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92-9.
11. Karlowsky JA, Thornsberry C, Jones ME, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis 2003;36:963-70.
12. Gonzales R, Steiner JF, Lum A, et al. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999;281:1512-19.
13. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA 1997;278:944-5.
14. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8:347-54.
15. Baquero F, Baquero-Artigao G, Canton R, et al. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50(suppl S2):27-37.
16. Samore MH, Magill MK, Alder SC, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 2001;108:856-65.
17. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing - 15th informational supplement. Wayne, PA: CLSI, 2005. (Approved standard, CLSI document M100-S15, vol 25).
18. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis 2001;32:1044-54.
19. Bingenheimer JB, Raudenbush SW. Statistical and substantive inferences in public health: issues in the application of multilevel models. Annu Rev Public Health 2004;25:53-77.
20. Snijders TA, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. London, England: SAGE Publications, 1999:266.
21. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998;17:1261-91.
22. Ekholm A, Jokinen J, Kilpi T. Combining regression and association modelling for longitudinal data on bacterial carriage. Stat Med 2002;21:773-91.
23. Temime L, Guillemot D, Boelle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004;48:2206-13.
24. Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 2004;132:433-41.
25. Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol 2001;9:438-44.
26. Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis 1997;25:1113-17.
27. Van Dyke Parunak H, Savit R, Riolo R. Agent-based modeling vs. equation-based modeling: a case study and users' guide. Paris, France, Proceedings of Workshop on Modeling Agent Based Systems (MABS), 1998.
28. Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001;286:49-56.
29. Dabernat H, Geslin P, Megraud F, et al. Effects of cefixime or coamoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother 1998;41:253-8.
30. Dubois J, St-Pierre C. In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens. Diagn Microbiol Infect Dis 2000;37:187-93.
31. Perry CM, Scott LJ. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs 2004;64:1433-64.
32. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95-104.
33. Jacobs MR, Bajaksouzian S, Windau A, et al. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. Clin Lab Med 2004;24:503-30.
34. Dagan R, Leibovitz E, Greenberg D, et al. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998;17:880-5.
35. Garcia-Rey C, Aguilar L, Baquero F, et al. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol 2002;40:2959-63.
36. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003;9:424-30.
37. Assessment of susceptibility testing practices for Streptococcus pneumoniae - United States, February 2000. MMWR Morb Mortal Wkly Rep 2002;51:392-4.
38. Fasola EL, Bajaksouzian S, Appelbaum PC, et al. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob Agents Chemother 1997;41:129-34.
39. Davies TA, Kelly LM, Jacobs MR, et al. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies. J Clin Microbiol 2000;38:1444-8.
40. Jorgensen JH, Ferraro MJ, McElmeel ML, et al. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994;32:159-63.
41. Huang SS, Finkelstein JA, Rifas-Shiman, SL, et al. Community-level predictors of pneumococcal carriage and resistance in young children. Am J Epidemiol 2004;159:645-54.
42. Sa-Leao R, Tomasz A, Santos Sanches I, et al. Pilot study of the genetic diversity of the pneumococcal nasopharyngeal flora among children attending day care centers. J Clin Microbiol 2002;40:3577-85.
43. Belongia EA, Sullivan BJ, Chyou PH, et al. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children. Pediatrics 2001;108:575-83.
44. Stratchounski LS, Kretchikova OI, Kozlov RS, et al. Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia. Pediatr Infect Dis J 2000;19:196-200.
45. Huebner RE, Wasas AD, Klugman KP. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg. S Afr Med J 2000;90:1116-21.
46. Barnes DM, Whittier S, Gilligan PH, et al. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995;171:890-6.
47. Henderson FW, Gilligan PH, Wait K, et al. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in a group day care. J Infect Dis 1988;157:256-63.
48. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
49. Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 1998;177:1003-12.
50. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998;279:365-70.
51. Corso A, Severina EP, Petruk VF, et al. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb Drug Resist 1998;4:325-7.
52. Mouz N, Di Guilmi AM, Gordon E, et al. Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for beta-lactam antibiotics. J Biol Chem 1999;274:19175-80.
53. Hansman D, Morris S. Pneumococcal carriage amongst children in Adelaide, South Australia. Epidemiol Infect 1988;101:411-17.
54. Bronsdon MA, O'Brien KL, Facklam RR, et al. Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions. J Clin Microbiol 2004;42:596-600.
55. Huebner RE, Dagan R, Porath N, et al. Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J 2000;19:1017-20.
56. Negri MC, Morosini MI, Loza E, et al. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1994;38:122-5.
57. Chesnel L, Carapito R, Croize J, et al. Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance. Antimicrob Agents Chemother 2005;49:2895-902.
58. Koopman JS, Lynch JW. Individual causal models and population system models in epidemiology. Am J Public Health 1999;89:1170-4.